About Symbio Proinnovera In November 2023 the merger of US-headquartered Symbio LLC with Münster-based Proinnovera created Symbio Proinnovera, one of the world’s largest specialized dermatology-focused clinical research organizations offering cost saving, time-efficient outsourced services for dermatological therapy formulation and clinical trial testing. The merged group, Symbio Proinnovera, provides consulting, testing and clinical research through every development stage, from concept...